Journal club 26.11.06

Defensins mediate skin inflammation and itch in psoriasis

Sharan Kumar Balaji1, Qin Zheng2, Huasheng Yu3, Joann Truong1, Luchiano Giovanni Benjamin Fernando1, Yining Liu1, Clara Shin3, Wenqin Luo3, Xinzhong Dong4 and

Xintong Dong1

Psoriasis is an inflammatory skin condition that features marked upregulation of keratinocyte-derived antimicrobial
peptides, particularly !-defensins. Yet, the functions of these peptides in skin inflammation remain
unclear. In this study, we used a defensin cluster-knockout mouse to evaluate the potential roles of defensins
as neuroimmune modulators in psoriasis. Deletion of the defensin gene cluster (Def conditional knockout) in
keratinocytes significantly attenuated imiquimod-induced psoriatic inflammation, with reduced hyperkeratosis,
erythema, scaling, and expression of inflammatory cytokines and chemokines. In addition, the Def conditionalknockout
mice exhibited reduced neutrophil and IL-17→ TCR”# T-cell infiltration in the psoriatic skin, indicating
a critical role of defensins in amplifying T helper 17 immunity. Behavioral analysis further revealed that
the loss of defensins reduced psoriatic itch, and we showed that human !-defensin 2 directly activated smalldiameter
Mrgpra3 neurons to elicit robust scratching. Overall, our study revealed that !-defensins play an
important role in mediating inflammation and itch associated with psoriasis by activating neutrophils, type 17
immune response, and pruriceptive sensory neurons, suggesting defensin signaling as a potential therapeutic
target in psoriasis.

Journal club 26.11.06 Read More »

Journal Club 26. 10. 30

Deep FLASH-seq profiling of purified canine sensory neurons uncovers species-specific signatures relevant to pain and itch

Paula Ledesma Fernandez a,b , Brandi Butler b , Heidi Theis c , Stefan Paulusch c , Elena De Domenico c , Greg A. Weir a , Andrew M. Bell a,b, *

Abstract
Naturally occurring pain and itch disorders in the domestic dog represent an important and underexploited opportunity for translational sensory neuroscience. These conditions largely mirror human disease, highlighting the need for detailed comparative understanding of canine somatosensory neurobiology. Here, we present a single-cell transcriptomic characterisation of the canine dorsal root ganglion (DRG), providing molecular insights into sensory neuron diversity in a species of direct veterinary and biomedical relevance. We develop a novel mechanical dissociation and fluorescence-activated cell sorting strategy enabling purification of intact whole neurons from adult canine DRG, followed by deep, full-length RNA sequencing using FLASH-seq. This approach yields high-quality transcriptional profiles with molecular depth analogous to deep neuronal profiling in human DRG, enabling resolution of neuronal identities and subtype-specific gene programs. Using these data, we identify canine sensory neuron clusters conforming to conserved principles of DRG molecular organization observed across species, including peptidergic and noncanonical peptidergic nociceptors, low-threshold mechanoreceptors, proprioceptors, and thermosensory populations. Cross-species comparisons with human and mouse DRG datasets reveal broad conservation of pain-and itch-relevant pathways and therapeutic targets, alongside biologically meaningful divergence. We further identify species-specific differences in subtype-restricted expression of the pharmacologically relevant receptors IL31RA and SSTR2, which we validate using in situ hybridization and contextualize with human spatial transcriptomic data. Finally, we provide evidence that domestication-associated genes are nonrandomly enriched in specific sensory neurons, suggesting that evolutionary history may have shaped somatosensory function. These data represent a resource for comparative sensory neuroscience and inform translational interpretation of pain and itch therapeutics across species.
Keywords: Canine, Dorsal root ganglion, Single-cell, FLASH-seq, Pain, Itch

Journal Club 26. 10. 30 Read More »

Journal Club 26.10.23

IL-13-Amphiregulin pathway exacerbates itch in allergic contact dermatitis

Xiaolong Dai 1, Xinrong Yan 1, Michael Kitching 2, Rengang Luo 2, Renkai Zhu 2, Owen Wang 3, Szymon Kupiec 4, Weiwei Chen 5, Jiafu Wang 2, Jianghui Meng 6

J Invest Dermatol 2026 Oct 5:S0022-202X(26)03764-4.  doi: 10.1016/j.jid.2026.09.852.Online ahead of print.

Itch is an instinctive sensory response that provokes scratching and serves as a protective mechanism against potential threats. It is a pervasive and distressing symptom across many dermatological and systemic disorders, particularly atopic dermatitis (AD) and allergic contact dermatitis (ACD), each of which affects nearly 20% of the population. Persistent itch disrupts the skin barrier, fuelling disease chronicity through a self-perpetuating itch–scratch cycle that worsens lesions and diminishes quality of life. The underlying mechanisms remain largely unknown.
Amphiregulin (AREG), recently implicated in chronic pain is a member of the epidermal growth factor (EGF) family and a type 2 cytokine–associated protein that binds to the epidermal growth factor receptor (EGFR) to regulate cell proliferation, differentiation, and migration (Zaiss et al., 2015). Beyond epithelial cells, AREG is also produced by mast cells, basophils, type 2 innate lymphoid cells (ILC2s), and regulatory CD4⁺ T cells (Zaiss et al., 2015). Initially expressed as a membrane-anchored precursor protein, AREG is cleaved by ADAM17 (a disintegrin and metalloprotease 17), facilitating EGFR signalling that contributes to inflammation and tissue repair. AREG has been implicated in multiple inflammatory disorders, including psoriasis, arthritis, and AD, by promoting inflammatory cytokine expression, keratinocyte proliferation, and epidermal remodelling. However, the role of AREG dysregulation in itch pathogenesis remains undefined. This study aims to elucidate the role of AREG signalling in skin upon T 2 cytokine stimulation and the resulting alterations in
H
neurocutaneous communication in both acute and chronic itch models. We will also evaluate the effect of an anti-AREG neutralising antibody on itch generation.

Journal Club 26.10.23 Read More »

Journal Club 26.10.16

Neuronal Mechanisms of Psoriatic Itch: Role of IL-17R/ERK/TRPV4 Signaling Pathway

Qiaojuan Zhang 1 7, Minji Jang 1 7, Fabiana C. Dias 1 7, Qian Zeng 1, Peng Wang 1, Heiley Tai 1, Eman Chattha 1, Jennifer Y. Zhang 2 3, Regina S.P. Lim 4, Wolfgang Liedtke 1 5 6, Yong Chen 1 3 5

1 Department of Neurology, Duke University School of Medicine, Durham, North Carolina, USA
2 Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA
3 Department of Pathology, Duke University School of Medicine, Durham, North Carolina, USA
4 Department of Dermatology, Changi General Hospital, Singapore, Singapore
5 Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina, USA
6 Department of Molecular Pathobiology, New York University, New York, New York, USA

Itch represents a major disease burden of psoriasis. Despite recent clinical studies showing the effectiveness of IL-17– and IL-17R–blocking antibodies in alleviating psoriatic itch, significant questions remain unanswered. Specifically, the crucial cellular site of action and the impacted signaling pathway of IL-17/IL-17R in psoriatic itch are elusive. Itch sensation relies on dorsal root ganglion (DRG) sensory neurons that transmit pruriceptive signals from the periphery to the CNS. IL-17RA and IL-17RC, 2 cognate receptors for IL-17, are expressed in DRG neurons. In this study, we demonstrated that IL-17RA and IL-17RC are upregulated in DRG neurons in a mouse model of psoriasis induced by imiquimod. Notably, conditional knockout of Il17ra or Il17rc in sensory neurons potently attenuated psoriasis-like itch. Furthermore, our in vitro assay with cultured neurons and in vivo experiment with animal model of psoriasis demonstrated that IL-17RA and IL-17RC upregulate the pruritic ion channel TRPV4 in DRG neurons through the extracellular signal–regulated kinase (ERK) signaling pathway. Specific deletion of Trpv4 or suppression of phosphorylation of ERK in DRG neurons mitigated psoriasis-like itch. These findings suggest that the IL-17R/ERK/TRPV4 signaling pathway in sensory neurons plays a significant role in psoriatic itch.

Keywords

Dorsal root ganglion sensory neurons; IL-17; Itch; Psoriasis; TRPV4

Journal Club 26.10.16 Read More »

Journal Club 2026.10.02

Endoplasmic Reticulum Stress in the Keratinocytes Contributes to Chronic Itch by Activation of Lipocalin 2/MC4R/TRPV1 Pathway

Wei Ge # 1 2, Yu Feng # 3, Li Zhang # 4, Qian-Liang Wang # 1, Cheng-Wei Zhang 5, Zhi-Hong Wang 6, Guo-Kun Zhou 7, Shi-Yu Sun 7, Xiu-Hua Miao 8, Tong Liu 9, Bin Wu 10, Jun Yan 11

Affiliations

  • 1Department of Orthopedics, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
  • 2Department of Orthopedics, Yancheng First People’s Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, 224000, China.
  • 3Department of Rheumatology and Immunology, The Fourth Affiliated Hospital of Soochow University, Suzhou, 215000, China.
  • 4Department of Anesthesiology, The First People’s Hospital of Kunshan Affiliated with Jiangsu University, Kunshan, 215300, China.
  • 5Department of Thoracic Surgery, Capital Medical University, Electric Power Teaching Hospital, Beijing, 100073, China.
  • 6Cambridge-Suda Genomic Resource Center, Suzhou Medical College, Soochow University, Suzhou, 215000, China.
  • 7Institute of Pain Medicine and Special Environmental Medicine, Nantong University, Nantong, 226001, China.
  • 8Department of Pain Management, Affiliated Hospital and Medical School of Nantong University, Nantong, 226001, China.
  • 9Institute of Pain Medicine and Special Environmental Medicine, Nantong University, Nantong, 226001, China. tongliu@ntu.edu.cn.
  • 10Department of Anesthesiology and Pain Rehabilitation, Cardiopulmonary and Critical Care Rehabilitation Center, Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), Tongji University School of Medicine, Shanghai, 200092, China. wubin0108@hotmail.com.
  • 11Department of Orthopedics, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China. cxyanjun@hotmail.com.

#Contributed equally.

Abstract

Endoplasmic reticulum (ER) stress plays a significant role in chronic pain, but its potential involvement in chronic itch remains largely unexplored and poorly understood. In the current study, we investigated whether ER stress signaling in keratinocytes contributes to the pathogenesis of chronic itch. Our behavioral tests showed that the ER stress inhibitor 4-PBA attenuated itch-related behaviors in both acute and chronic itching mouse models, and reduced compound 48/80 and serotonin-induced activity of dorsal root ganglion (DRG) neurons. qPCR and western blotting revealed that the ER stress-related proteins and Lipocalin-2 (LCN2) were significantly elevated in the affected skin under chronic itch conditions and in cultured keratinocyte HaCaT cells and mice skin keratinocytes. The ELISA test showed that the level of LCN2 increased significantly in plasma but not in DRG tissue, from both acetone-ether-water (AEW) induced dry skin and imiquimod (IMQ) induced psoriasis model mice. Current clamp recording demonstrated that LCN2 induced hyperexcitability in dorsal root ganglia neurons, which could be abolished by HS024, the inhibitor of melanocortin receptor 4 (MC4R). In addition, pharmacological inhibition of transient receptor potential vanilloid 1 (TRPV1) or TRPV1 knockout blocked LCN2-induced hyperexcitability in DRG neurons. In conclusion, this study demonstrated that keratinocyte ER stress is involved in chronic itch genesis by releasing LCN2, which sensitized primary sensory neurons via TRPV1. These findings suggested that inhibition of ER stress in keratinocytes could be a promising therapeutic strategy for treating chronic itch.

Keywords: Endoplasmic reticulum stress; Itch; Keratinocyte; LCN2; TRPV1.

Journal Club 2026.10.02 Read More »

Journal club 26. 09. 11

Endosomal MrGPRX1 signaling sensitizes TRPV1 to enhance itch

Paz Duran1,2,3, Jeffri S. Retamal2,4, Marcella de Amorim Ferreira1,2,3, Kai Trevett1,3, Evan Chen1,3 and Dane D. Jensen1,2,3*
1Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY,
United States, 2Translational Research Center, College of Dentistry, New York University, New York, NY,
United States, 3NYU Pain Research Center, College of Dentistry, New York University, New York, NY,
United States, 4Department of Chemistry and Biology, University of Santiago Chile, Santiago, Chile

G protein-coupled receptors (GPCRs) and TRPV (transient receptor potential
vanilloid) channels are crucial for signal transduction in physiological
processes, including neurotransmission, pain, and itch. Downstream effectors
of GPCR signaling can directly stimulate TRPV channels or enhance their
sensitivity to stimuli, a process known as TRPV sensitization. Traditionally,
GPCRs are activated at the cell surface by extracellular agonists, triggering
signaling cascades. Recent evidence suggests GPCRs continue to signal
from intracellular organelles. The human Mas-related G-protein coupled
receptor X1 (MrGPRX1) is a GPCR expressed in primary sensory neurons
involved in nociception and pruritus. Recent studies demonstrated how
intracellular GPCR signaling regulates neuronal activity. However, there is no
evidence characterizing MrGPRX1 trafficking or intracellular signaling. Herein,
we characterized MrGPRX1 signaling within the endosomal network and its role
in sensitizing TRPV1 channels to enhance itch signaling. Utilizing subcellular
targeted biosensors, we demonstrated MrGPRX1 can traffic and signal from
endosomes. Immunofluorescence analysis showed that MrGPRX1 internalizes
following BAM8-22 stimulation. BRET assays revealed that MrGPRX1 activation
induces Gαq and β-arrestin-1 recruitment to the plasma membrane and
early endosomes. Inhibition of dynamin or clathrin blocked BAM8-22-induced
MrGPRX1 endocytosis and decreased nuclear extracellular signal-regulated
kinase (ERK) signaling. Calcium signaling confirmed that MrGPRX1-mediated
TRPV1 sensitization is mediated by protein kinase C and ERK activation.
Our findings reveal a novel role for MrGPRX1 endosomal signaling in TRPV1
sensitization. Understanding the mechanisms of MrGPRX1 signaling offers
valuable insights into differentiating between pain and itch pathways, aiding in
the development of targeted therapies for chronic pain and persistent itch.

KEYWORDS
endosome, intracellular signaling, MrGPRs, signal transduction, transient receptor
potential channels (TRP Channels)

Journal club 26. 09. 11 Read More »

26.09.04 Journal Club

Fibroblast MrgprX2/B2 signaling drives hypertrophic
scar fibrosis

Hypertrophic scarring (HTS) represents a common clinical challenge characterized by excessive fibroblast
activation and tissue fibrosis. However, the upstream signals driving pathological fibroblast proliferation
remain poorly understood. Here, we identify the G protein-coupled receptor MrgprX2 (human)/MrgprB2
(mouse), traditionally restricted to mast cells, as an inducible pro-fibrotic receptor in dermal fibroblasts dur
ing HTS progression. MrgprX2 is markedly upregulated in dermal fibroblasts from HTS, and pharmacological
inhibition of MrgprX2 significantly reduces fibrosis in humanized skin organoid models. In mouse studies, the
endogenous peptide LL37 emerged as an MrgprX2/B2 activator in fibroblasts, triggering calcium influx,
transforming growth factor β1 (TGF-β1) secretion, and proliferation. Genetic ablation of MrgprB2 in fibro
blasts significantly reduced fibrosis in vivo, establishing the LL37-MrgprX2/B2-TGF-β1 axis as a key mediator
of fibroblast activation and fibrotic remodeling. Together, our findings position MrgprX2/B2 as a critical mo
lecular link between tissue injury-associated signals and fibrotic pathology, offering a promising therapeutic
target for fibroblast-driven fibrosis in HTS.

26.09.04 Journal Club Read More »

Development of itch biosensors with engineering membrane receptors thatare coupled to field-effect transistors

A B S T R A C T
Biosensors inspired by biological sensory systems are valuable tools for detecting physiological and environmental
stimuli with high degrees of specificity and sensitivity. An itch irritant biosensor to detect environmental
changes or pruritogenic substances in human blood or tissues highly associated with inflammation and prevalent
conditions like atopic dermatitis (AD) has not been developed. To address this gap, we developed a novel bioelectronic
sensor by integrating the human itch receptor Mas-related G-protein-coupled receptor X2 (MRGPRX2)
with a graphene field-effect transistor (GFET). This MRGPRX2–GFET biosensor covalently immobilizes functional
receptors, enabling direct conversion of ligand-binding events into quantifiable electrical signals. We
demonstrate that the sensor can detect known MRGPRX2 agonists with exceptional sensitivity and specificity,
achieving a detection limit for SP at approximately 7 pM. Molecular dynamics (MD) simulations and mutational
effects reveal that ligand binding induces cytoplasmic conformational rearrangements in MRGPRX2, strengthening
receptor–graphene coupling and providing a mechanistic basis for signal transduction. Importantly, the
biosensor effectively distinguishes plasma samples from AD patients and healthy controls by capturing different
electrical signal responses. In our study, we establish a versatile platform for diagnosing and subtyping chronic itch disorders and offer a generalizable strategy for developing membrane receptor-based multiplexed “itch- print” biosensors.

Development of itch biosensors with engineering membrane receptors thatare coupled to field-effect transistors Read More »

Journal Club 26.08.14

Platelets Orchestrate a Neuroimmune Axis Driving Cutaneous Inflammation and Itch

Ximin Hu1,2,3, Fujun Wang1,4, Ting Wang2, Yifei Liu2, Lei Zhang2,
Libei Liu2,3, Liang Cao5, Shaofeng Pu6, Ronghua Yang1, and Jing Feng2,7*
1Department of Burn and Plastic Surgery, School of Medicine, the Second Affiliated Hospital of South
China University of Technology (Guangzhou First People’s Hospital), Guangzhou 510180, China. 2State
Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Shanghai 200000, China.
3Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan 410000,
China. 4School of Basic Medicine, Qiqihar Medical University, Qiqihar, Heilongjiang 161006, China.
5Department of Chinese Medicine, The Second Affiliated Hospital of Air Force Medical University, Xi’an,
Shaanxi 710038, China. 6Department of Pain Management, Shanghai Jiao Tong University Affiliated
Sixth People’s Hospital, 200000, Shanghai, China. 7University of Chinese Academy of Sciences, Beijing
100000, China.
*Address correspondence to: shaofpu@sjtu.edu.cn (S.P.); eyyangronghua@scut.edu.cn (R.Y.); fengjing@
simm.ac.cn (J.F.)


Platelets are traditionally recognized for their roles in hemostasis, but their involvement as active immune
modulators in cutaneous neuroimmune signaling remains poorly understood. In this study, we integrated
multi-modal genetic and pharmacological strategies to investigate the functional contribution of platelets
to skin inflammation and chronic itch. Optogenetic activation of platelets was sufficient to elicit localized
skin inflammation, erythema, and robust pruritus, with transcriptomic profiling of lesions showing strong
concordance with the clinical signatures of atopic dermatitis (AD). In experimental AD models, platelet
depletion markedly reduced scratching behavior, inflammatory cell infiltration, and C-fiber excitability,
whereas platelet activation exacerbated these phenotypes. Mechanistically, activated platelets release
serotonin [5-hydroxytryptamine (5-HT)], which compromises vascular integrity and facilitates platelet
extravasation into the dermis. This “neuroimmune hub” promotes macrophage recruitment and sensitizes
TRPV1+ pruriceptors. Transcriptomic analysis revealed that platelet-derived 5-HT drives these processes
via HTR2B and HTR7 signaling. Specifically, genetic ablation of HTR2B in TRPV1+ neurons selectively
impaired itch transmission. Furthermore, re-analysis of clinical datasets confirmed the enrichment of
HTR2B and HTR7 in skin macrophage populations during inflammation. Systemic administration of
HTR antagonists or the anti-platelet agent clopidogrel markedly attenuated both inflammation and
pruritus across multiple models. Our findings identify the platelet–immune–neuron axis as a key driver
of cutaneous dysfunction and a promising therapeutic target for chronic inflammatory skin disorders.

Journal Club 26.08.14 Read More »

Journal Club 26.08.06

Chi3l1 Knockout Mitigates Chronic Itch and Cutaneous Inflammation in Mice

Sam Kahler1, Brigid Betz-Stablein1, Fabian Lee1, Joachim Torrano1, Monika Janda2, Clare Primiero1, H, Peter Soyer1 and Dilki Jayasinghe

CHI3L1, also known as YKL-40, is a 40- kDa glycoprotein that is overexpressed
in patients with atopic dermatitis (AD) and is induced by various proinflammatory
cytokines. This protein interacts with multiple receptors (He et al,
2013; Lee et al, 2016), and its serum levels corelate with the severity of AD in
humans. CHI3L1 regulates T helper type 2 cytokines and modulates IgE release
(Curtiss et al, 2023; Lee et al, 2022). Antibody therapy targeting CHI3L1 has
been shown to improve skin inflammation in AD in mice (Lee et al, 2022; Yu
et al, 2024). CHI3L1 also activates IL- 13Ra2 (Kwak et al, 2019). Although IL-
13Ra2 was traditionally considered as a decoy receptor, our studies have
revealed its crucial role in AD associated itch, with increased expression
observed in patients with AD (Xiao et al, 2021). Despite these findings, the
role of CHI3L1 in chronic itch sensation remains largely unexplored. This study
aims to elucidate the role of CHI3L1 in itch by investigating its interactions with
IL-13Ra2 and IL-31 receptor, which are key itch receptors (Meng et al, 2018). In
addition, our study explored the function and the effects of CHI3L1 gene
knockout (KO) on itch generation and related signaling pathways.

Journal Club 26.08.06 Read More »

Scroll to Top